Ga direct naar de inhoud

Ga direct naar de navigatie

Uitgave van

Archief voor de categorie ‘Overig’

Roche’s Ocrevus shows earlier, better outcomes in primary progressive and relapsing MS

Roche has unveiled new five-year data from three Phase 3 open-label extension studies investigating the efficacy of Ocrevus (ocrelizumab) in the treatment of relapsing and primary progressive forms of multiple sclerosis (MS), showing a wide range of benefits over other therapies at the 34th Congress of the European Committee for the Treatment and Research in […]

Bron: InPharm.com Meer lezen »

Lilly, Merck and Pfizer lead pharma’s share price gains through 9 months: report

Several big drugmakers have posted big share price gains in the first nine months of the year, while other companies have seen only modest declines, according to a report from Vantage.

Bron: FiercePharma Meer lezen »

BioArctic’s medical device gets European patent to treat patients with complete spinal cord injury

BioArctic AB, a Swedish research─based biopharma company, announced that the European Patent Office (EPO) has issued a decision to grant the company’s patent application in Europe, EP12815796.3, for a medical device

Bron: Pharma Biz Meer lezen »

EU officials clash with Chinese firm on drug factory inspection

European medicines regulators have issued a notice that an ingredient for a generic brain cancer drug made in China does not meet manufacturing standards, after inspectors were refused entry to a factory run by Jiangsu Yew Pharmaceutical Co. Ltd.

Bron: Reuters Health Meer lezen »

Humor in content is serious business

De beste marketing voelt helemaal niet als marketing. Hoe kan het toch dat veel bedrijven nog erg terughoudend zijn om hun boodschap met humor te brengen? In dit artikel deel ik voorbeelden van het gebruik van humor in content. Wanneer werkt het wel en wanneer niet?

Bron: Frankwatching.nl Meer lezen »

National Insulin Summit highlights on innovations in insulin therapy

The National Insulin Summit, conducted by Diabetes Research Society (DIABAID) and supported by Novo Nordisk, the world leader in diabetes care was inaugurated by leading endocrinologists.

Bron: Pharma Biz Meer lezen »

Influencer Marketing Event: ‘Je moet er op tijd bij zijn om het mee te maken’

Het eerste Influencer Marketing Event is in volle gang. Ruim 300 marketeers, influencers en andere marcomprofessionals zijn naar DeFabrique in Utrecht afgereisd om meer te weten te komen over het fenomeen influencer marketing.

Bron: MarketingTribune Meer lezen »

New malaria drug starts clinical trials

After decades a new drug against malaria has been developed and first clinical trials of this new investigational drug is soon to begin. Enrolment for the same has already started. This study is to be sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institutes of Health (NIH). It is […]

Bron: News-Medical.Net Meer lezen »

LinkedIn: 7 inzichten voor succesvolle posts in B2B

Hoe zorg je ervoor dat er zoveel mogelijk mensen op jouw LinkedIn-posts klikken? Bij mijn B2B-opdrachtgever doen we erg ons best zoveel mogelijk lezers te trekken. Dat lukte steeds beter. Lees hier verder voor het volledige bericht.

  Meer lezen »

Drug safety: UK and EU post-Brexit

What does Brexit mean for drug safety in Europe and the United Kingdom? Louis Goss looks into Britain’s exit from the European Union and asks what the future might hold for pharmacovigilance on both sides of the channel.

Bron: InPharm.com Meer lezen »

« Oudere artikelen |